Inhibition of protease-activated receptor (PAR1) reduces activation of the endothelium, coagulation, fibrinolysis and inflammation during human endotoxemia - Schoergenhofer, C; Schwameis, M; Gelbenegger, G (Thromb Haemost, 2018)
, et al.